TP53 and leukemia: In the previous meta-analysis, which was limited by the number of studies, the authors only performed subgroup analyses on the association between TP53 Arg72Pro polymorphism, the risk of AML (n = 5), and the risk of other types of leukemia (n = 4), and the results were consistent with ours.